Tempus AI Earnings Preview: What Investors Should Know
Tempus AI (NASDAQ: TEM) is preparing to announce its quarterly earnings on a date set for the near future. Investors are keenly interested in what this report may reveal about the company's financial health and future expectations.
Analysts' Predictions for Tempus AI
Current estimates suggest that Tempus AI will report an earnings per share (EPS) of $-0.34. This figure indicates a continued period of loss as the company works toward profitability.
What to Expect from the Earnings Announcement
The upcoming announcement from Tempus AI is highly anticipated, with investors eagerly seeking updates on whether the company will exceed estimates and provide favorable guidance for the upcoming quarter. Guidance has been a key term for investors, often serving as a compass for stock price fluctuations.
Review of Past Earnings Performance
In the last quarter, Tempus AI surprised investors by beating EPS expectations by $0.03. This positive news resulted in a significant 12.59% jump in the share price within just a day following the earnings release.
Examining Recent Earnings Trends
Looking back at Tempus AI's previous quarterly performance reveals an interesting trend. During the last four quarters, EPS estimates varied, showcasing the company's unpredictable yet evolving financial landscape. Below is an overview of findings from previous quarters:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.15 | -0.44 | -1.30 |
| EPS Actual | -0.24 | -0.18 | -0.25 | -0.63 |
| Price Change % | 13.0% | -15.0% | -10.0% | -5.0% |
Current Market Performance of Tempus AI's Stock
As of the latest trading session, Tempus AI shares have been priced at approximately $55.53. Observing the company's stock performance over the past 52 weeks, it's noteworthy that shares have surged by 47.64%. Such positive returns generally foster a bullish sentiment among long-term investors.
Insights from Analysts on Tempus AI
For investors, keeping up with market sentiments and the prevailing expectations is crucial. Analysts currently hold a consensus rating of Neutral for Tempus AI, which derives from five individual assessments. They project an average one-year price target of $69.6, which suggests a potential upside of 25.34%.
Comparative Analysis with Industry Peers
To better understand Tempus AI's positioning, it's beneficial to compare its ratings and anticipated price targets with key competitors in the industry:
- Revvity holds an Outperform rating with an average one-year price target of $112.5, indicating a substantial upside potential of 102.59%.
- Bio-Techne is rated Buy, with an average target of $68.8, demonstrating a potential upside of 23.9%.
- Medpace Holdings maintains a Neutral rating and has a striking average price target of $410.88, representing an astonishing potential upside of 639.92%.
Summary of Peer Performance Metrics
In analyzing the performance across the industry, Tempus AI exhibits weaker metrics compared to its counterparts:
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Tempus AI | Neutral | 75.38% | $155.20M | -35.57% |
| Revvity | Outperform | 4.13% | $392.56M | 0.71% |
| Bio-Techne | Buy | 4.20% | $214.56M | 1.10% |
| Medpace Holdings | Neutral | 14.24% | $180.01M | 23.57% |
The current evaluation gives Tempus AI a lower ranking in Revenue Growth, along with a lower Gross Profit margin. It also faces challenges in achieving a satisfactory Return on Equity, positioning it at a disadvantage relative to competitors.
The Innovation Story of Tempus AI
Tempus AI Inc is a pioneering technology firm focusing on unlocking healthcare data from silos through its Tempus Platform. This platform features an advanced operating system designed to enhance the usefulness of healthcare data while employing AI and generative algorithms for more accurate laboratory testing.
Financial Breakdown of Tempus AI
Market Cap Insights: The company's market capitalization is below industry standards, potentially reflecting limited growth expectations or operational capacity.
Revenue Growth Insights: Tempus AI's revenue growth over the past three months has been impressive, with a rate of approximately 75.38% as of the last reporting date this year. This impressive growth rate surpasses industry averages, indicating the company's strong upward trajectory.
Net Margin Consideration: Despite a healthy revenue growth rate, Tempus AI still faces challenges with a net margin of -26.6%, revealing potential concerns regarding overall cost management and profitability.
Return on Equity (ROE): The company's ROE stands at -35.57%, which is below industry figures, indicating obstacles in leveraging equity for maximum returns.
Debt Considerations: With a debt-to-equity ratio of 2.63, Tempus AI leans significantly on borrowed funds, raising its financial risk profile.
Final Thoughts on Tempus AI
The upcoming earnings announcement for Tempus AI is set to draw substantial interest from investors seeking clarity on its financial direction and strategic growth perspective. As investors tune into the unfolding story, it will be crucial to observe how the company navigates its challenges and capitalizes on its growth opportunities.
Frequently Asked Questions
What is the expected EPS for Tempus AI?
The expected EPS for Tempus AI is projected at $-0.34.
How has Tempus AI’s stock performed recently?
Recently, Tempus AI shares are noted to have increased by 47.64% over the past year.
What is the consensus rating for Tempus AI?
The consensus rating for Tempus AI is currently Neutral from analysts.
How does Tempus AI compare with its competitors?
Compared to competitors, Tempus AI has lower revenue growth and profit margins.
What challenges does Tempus AI face?
Tempus AI faces challenges in profitability reflected in its net margins and return on equity.
